However, the identification of the oncogenic events that cooperate with IL7R mutational activation in originating the disease is still limited, and, most important, whether mutant IL-7Rα alone can trigger T-ALL development remains unaddressed. This evidence concerns the gene IL7R and acute lymphoblastic leukemia.